Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that the meeting of Board of Directors of the Company is scheduled to be held on Monday, August 12, 2019 at 2.00 p.m. at Corporate Office of the Company viz. 974, 9th Floor, Aggarwal Millenium Tower-II, Netaji Subhash Place, Pitampura, New Delhi-110034, to consider & approve the Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th, 2019. Further, in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Equity Shares of the Company by Designated Persons (and their immediate relatives) has already been closed with effect from 1st July, 2019 up to the completion of 48 hours after the declaration of unaudited Financial Results for the 1st quarter ended 30th June 2019 to the Stock Exchange.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |